You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RNA Disposition Disclosure
Winslow Brendan R. · SEC Form 4 · Filed Sep 22, 2026
Disposition
Calculated transaction value
$60.34K
Winslow Brendan R. Chief Financial Officer
RNA
Transaction date
Sep 18, 2026
Public filing date
Sep 22, 2026
Filing lag
Filed 4 days later
RNA daily price context
Close on/before transaction
$8.95
Sep 18, 2026
First close after public filing
$8.33
Sep 23, 2026
30-day return after filing
-2.04%
Through Oct 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,742 shares @ $8.95
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001193125-26-397941
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$60.34K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Atrium Therapeutics, Inc. RNA Current | Disposition | Sep 18, 2026 | $60.34K |